You are on page 1of 10

22 May 2023 | 9:09PM CST

TSMC (2330.TW)
Prolonged inventory correction cycle with weaker demand recovery;
Buy

reiterate Buy but cut TP to NT$615

2330.TW 12m Price Target: NT$615.00 Price: NT$531.00 Upside: 15.8% Bruce Lu
+852-2978-6368 | bruce.lu@gs.com
Goldman Sachs (Asia) L.L.C., Taipei Branch
TSM 12m Price Target: $101.00 Price: $92.58 Upside: 9.1%
Evelyn Yu
+886(2)2730-4187 | evelyn.yu@gs.com
We are trimming our TSMC 2023-2025E earnings by 3-5% given a Goldman Sachs (Asia) L.L.C., Taipei Branch

weaker 2H23 end demand recovery mainly from smartphone and


PC. Overall semi inventory digestion is progressing slower than
expected with Greater China semis inventory days further climbing
to 107 days in 1Q23 (vs 100 days in 4Q22). On the inventory value
For the exclusive use of ALLEN.HAI@KGI.COM

side, the number only declined by 1% QoQ at IDM/fabless/IC Key Data __________________________________
distributors, while foundry grew 2% QoQ. In light of the prolonged Market cap: NT$13.8tr / $448.8bn
Enterprise value: NT$13.3tr / $433.7bn
inventory correction cycle, we cut our TSMC UTR (utilization rate) for 3m ADTV: NT$11.7bn / $383.0mn
Taiwan
both its advanced and matured nodes. Taiwan Semiconductor
M&A Rank: 3
Leases incl. in net debt & EV?: Yes

We are now expecting 2023 revenue to decline by 10% YoY GS Forecast ________________________________
12/22 12/23E 12/24E 12/25E
In the near term, we are looking for a 6.6% QoQ decline for its Revenue (NT$ mn) New 2,263,891.3 2,076,812.5 2,653,029.6 3,089,606.0
Revenue (NT$ mn) Old 2,263,891.3 2,140,808.4 2,742,903.3 3,187,586.5
2Q23E revenue. For 2023, we model a -10.0% YoY revenue (vs
EBITDA (NT$ mn) 1,558,533.1 1,402,278.9 1,872,609.3 2,202,565.0
-7.3% YoY previously), before a +27.3% rebound in 2024E as EPS (NT$) New 39.20 28.35 38.43 45.00
EPS (NT$) Old 39.20 29.83 39.59 46.59
supported by end demand recovery and stronger ramp for its 3nm P/E (X) 13.2 18.7 13.8 11.8
P/B (X) 4.5 4.1 3.4 2.9
(all in USD terms). We are now forecasting 5nm UTR to be ~75% in Dividend yield (%) 2.1 2.3 3.2 4.0
2H23 from 75-90% (vs 70-80% in 1H23), and 7nm UTR to 50-55%

b2517faa3a7e11e094d300215ad26546
CROCI (%) 26.4 19.1 21.8 23.0

in 2H23 from 50-60% (vs 50-65% in 1H23). We also lower our 3/23 6/23E 9/23E 12/23E
EPS (NT$) 7.98 6.34 6.75 7.28
8-inch capacity UTR to 70-75% in 2H23 from 70-85% (vs 70-85% in
1H23) as we see non-3C demand weakness to persist. GS Factor Profile ____________________________
Growth

Financial Returns
Lowering capex to factor in a slower capacity ramp schedule
Multiple
On the back of the slower end demand recovery, we cut our capex
forecasts for 2023/2024/2025E to US$31bn/US$27bn/US$36bn Integrated

from US$32bn/US$32bn/US$40bn, respectively. We believe TSMC


Percentile 20th 40th 60th 80th 100th
is likely push out its ramp up schedule of its US fabs expansion, and
2330.TW relative to Asia ex. Japan Coverage
we are now factoring in its first phase capacity (N4) to ramp only in 2330.TW relative to Taiwan Semiconductor
2025 (vs by 2024 as guided), and second phase capacity (N3) to see
Source: Company data, Goldman Sachs Research estimates.
further delay (vs guidance of N3+N4 to ramp by 2026). Note that See disclosures for details.

our 2023E capex is now even lower than TSMC’s low end range of

Goldman Sachs does and seeks to do business with companies covered in its research reports. As a result,
investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this
report. Investors should consider this report as only a single factor in making their investment decision. For Reg AC
certification and other important disclosures, see the Disclosure Appendix, or go to
www.gs.com/research/hedge.html. Analysts employed by non-US affiliates are not registered/qualified as research
analysts with FINRA in the U.S.
Goldman Sachs TSMC (2330.TW)

TSMC (2330.TW) Income Statement (NT$ mn) _______________________________


Buy Rating since May 7, 2019 Total revenue
12/22
2,263,891.3
12/23E
2,076,812.5
12/24E
2,653,029.6
12/25E
3,089,606.0
Cost of goods sold (915,536.5) (982,764.3) (1,230,053.8) (1,425,185.9)
SG&A (63,813.7) (66,662.1) (77,209.2) (88,409.2)
Ratios & Valuation _______________________________________ R&D (163,262.2) (181,628.1) (195,628.1) (229,628.1)
12/22 12/23E 12/24E 12/25E Other operating inc./(exp.) -- -- -- --
P/E (X) 13.2 18.7 13.8 11.8 EBITDA 1,558,533.1 1,402,278.9 1,872,609.3 2,202,565.0
P/B (X) 4.5 4.1 3.4 2.9 Depreciation & amortization (437,254.3) (556,521.0) (722,470.8) (856,182.3)
FCF yield (%) 3.9 1.8 7.1 7.0 EBIT 1,121,278.9 845,758.0 1,150,138.4 1,346,382.7
EV/EBITDAR (X) 8.3 9.5 6.8 5.5 Net interest inc./(exp.) 8,272.4 12,585.0 15,509.5 20,119.8
EV/EBITDA (excl. leases) (X) 8.3 9.5 6.8 5.5 Income/(loss) from associates 7,798.4 6,121.5 6,786.3 6,677.1
CROCI (%) 26.4 19.1 21.8 23.0 Pre-tax profit 1,144,190.7 867,077.8 1,172,434.2 1,373,179.6
ROE (%) 39.8 23.2 26.8 26.5 Provision for taxes (127,290.2) (132,118.4) (176,012.8) (206,341.9)
Net debt/equity (%) (17.0) (14.0) (27.7) (33.9) Minority interest (370.3) 150.1 150.1 150.1
Net debt/equity (excl. leases) (%) (17.0) (14.0) (27.7) (33.9) Preferred dividends -- -- -- --
Interest cover (X) 79.2 49.6 86.2 183.4 Net inc. (pre-exceptionals) 1,016,530.2 735,109.5 996,571.5 1,166,987.8
Days inventory outst, sales 33.4 48.4 48.9 51.0 Post-tax exceptionals -- -- -- --
Receivable days 34.6 41.1 42.6 52.9 Net inc. (post-exceptionals) 1,016,530.2 735,109.5 996,571.5 1,166,987.8
Days payable outstanding 181.0 183.6 184.5 231.1 EPS (basic, pre-except) (NT$) 39.20 28.35 38.43 45.00
DuPont ROE (%) 34.3 21.6 24.5 24.5 EPS (diluted, pre-except) (NT$) 39.20 28.35 38.43 45.00
Turnover (X) 0.5 0.4 0.4 0.5 EPS (basic, post-except) (NT$) 39.20 28.35 38.43 45.00
Leverage (X) 1.7 1.6 1.5 1.4 EPS (diluted, post-except) (NT$) 39.20 28.35 38.43 45.00
Gross cash invested (ex cash) (NT$) 6,390,285.9 7,424,826.7 8,163,191.9 9,221,620.7 DPS (NT$) 11.00 12.00 17.00 21.50
Average capital employed (NT$) 2,145,407.7 2,693,424.4 2,938,024.7 3,047,095.2 Div. payout ratio (%) 28.1 42.3 44.2 47.8
BVPS (NT$) 113.60 130.82 156.50 183.00
Balance Sheet (NT$ mn) __________________________________
Growth & Margins (%) ____________________________________ 12/22 12/23E 12/24E 12/25E
12/22 12/23E 12/24E 12/25E Cash & cash equivalents 1,342,814.1 1,331,712.5 1,681,621.6 1,866,485.4
For the exclusive use of ALLEN.HAI@KGI.COM

Total revenue growth 42.6 (8.3) 27.7 16.5 Accounts receivable 231,408.8 236,458.5 383,051.4 511,910.2
EBITDA growth 45.3 (10.0) 33.5 17.6 Inventory 221,149.1 329,648.3 380,577.5 482,763.1
EPS growth 70.4 (27.7) 35.6 17.1 Other current assets 257,524.7 246,302.4 246,302.4 246,302.4
DPS growth (0.0) 9.1 41.7 26.5 Total current assets 2,052,896.7 2,144,121.8 2,691,553.0 3,107,461.2
EBIT margin 49.5 40.7 43.4 43.6 Net PP&E 2,693,837.0 3,031,668.9 3,138,071.8 3,384,543.2
EBITDA margin 68.8 67.5 70.6 71.3 Net intangibles 25,999.2 18,646.5 11,112.8 3,579.0
Net income margin 44.9 35.4 37.6 37.8 Total investments 68,927.9 74,996.3 81,782.6 88,459.7
Other long-term assets 123,118.1 122,509.5 122,509.5 122,509.5
Price Performance _______________________________________ Total assets 4,964,778.9 5,391,943.0 6,045,029.6 6,706,552.6
2330.TW (NT$) Taiwan SE Weighted Index Accounts payable 510,823.1 478,042.7 765,325.9 1,039,738.5
Short-term debt 0.0 0.0 0.0 0.0
600 22,000
Short-term lease liabilities -- -- -- --
550 20,000 Other current liabilities 433,403.7 427,038.6 427,038.6 427,038.6
Total current liabilities 944,226.8 905,081.3 1,192,364.4 1,466,777.1
500 18,000
Long-term debt 839,096.5 854,785.1 554,785.1 254,785.1
450 16,000 Long-term lease liabilities -- -- -- --
400 14,000 Other long-term liabilities 220,966.7 225,071.7 225,071.7 225,071.7
Total long-term liabilities 1,060,063.2 1,079,856.8 779,856.8 479,856.8
350 12,000 Total liabilities 2,004,290.0 1,984,938.1 1,972,221.3 1,946,633.9

b2517faa3a7e11e094d300215ad26546
Preferred shares -- -- -- --
Jul-22 Oct-22 Jan-23 Apr-23
Total common equity 2,945,653.2 3,392,441.9 4,058,379.5 4,745,624.0
3m 6m 12m Minority interest 14,835.7 14,563.0 14,428.9 14,294.7
Absolute 4.7% 8.1% 0.2% Total liabilities & equity 4,964,778.9 5,391,943.0 6,045,029.6 6,706,552.6
Rel. to the Taiwan SE Weighted Index (0.2)% (2.8)% (0.0)% Net debt, adjusted (503,717.6) (476,927.4) (1,126,836.5) (1,611,700.2)
Source: FactSet. Price as of 22 May 2023 close.
Cash Flow (NT$ mn) ______________________________________
12/22 12/23E 12/24E 12/25E
Net income 1,016,530.2 735,109.5 996,571.5 1,166,987.8
D&A add-back 437,254.3 556,521.0 722,470.8 856,182.3
Minority interest add-back 370.3 (150.1) (150.1) (150.1)
Net (inc)/dec working capital 52,321.6 (146,329.4) 89,761.1 43,368.3
Other operating cash flow 104,122.8 39,296.4 (6,786.3) (6,677.1)
Cash flow from operations 1,610,599.2 1,184,447.5 1,801,867.1 2,059,711.1

Capital expenditures (1,082,672.1) (941,318.6) (821,340.0) (1,095,120.0)


Acquisitions -- -- -- --
Divestitures -- -- -- --
Others (108,256.1) 30,266.8 -- --
Cash flow from investing (1,190,928.2) (911,051.8) (821,340.0) (1,095,120.0)

Repayment of lease liabilities -- -- -- --


Dividends paid (common & pref) (285,234.2) (285,223.5) (330,633.9) (479,743.3)
Inc/(dec) in debt 84,022.6 9,400.3 (300,000.0) (300,000.0)
Other financing cash flows 59,364.5 (8,674.0) 16.0 16.0
Cash flow from financing (141,847.1) (284,497.3) (630,618.0) (779,727.4)
Total cash flow 277,823.9 (11,101.6) 349,909.1 184,863.8
Free cash flow 527,927.1 243,128.8 980,527.1 964,591.1

Source: Company data, Goldman Sachs Research estimates.

22 May 2023 2
Goldman Sachs TSMC (2330.TW)

guidance of US$32bn.

Exhibit 1: Greater China Semis coverage: avg. inventory days up to Exhibit 2: Foundry inventory days grew to 98 days in 1Q23 (vs 93
107 in 1Q23 (vs 100 days in 4Q22) days in 4Q22)

(US$mn)
IC design/ IDM Foundry OSAT Inventory days Inventory Inventory days
(US$mn)
12,000 120
30,000 120
107
10,000 100
25,000 100
85 81 98
76
20,000 71 80 8,000 80
64
56
15,000 60 6,000 60

10,000 40 4,000 40

5,000 20 2,000 20

- - - -
1Q15
2Q15

2Q16
3Q16

4Q17
1Q18

2Q19
3Q19

3Q20
4Q20

1Q22
2Q22
3Q15
4Q15
1Q16

4Q16
1Q17
2Q17
3Q17

2Q18
3Q18
4Q18
1Q19

4Q19
1Q20
2Q20

1Q21
2Q21
3Q21
4Q21

3Q22
4Q22
1Q23

3Q15
4Q15

1Q17
2Q17

3Q18
4Q18

4Q19
1Q20

2Q21
3Q21

4Q22
1Q23
1Q15
2Q15

1Q16
2Q16
3Q16
4Q16

3Q17
4Q17
1Q18
2Q18

1Q19
2Q19
3Q19

2Q20
3Q20
4Q20
1Q21

4Q21
1Q22
2Q22
3Q22
Companies include: IC design/IDM: Goodix, GigaDevice, Maxscend, Montage, CR Micro, SG Source: Company data, Data compiled by Goldman Sachs Global Investment Research
Micro, Silan, Will Semi, GalaxyCore, StarPower, Rockchip, SinoWealth, Amlogic, 3Peak,
Espressif, Chipown, Mediatek, Novatek, Silergy, Parade, and Realtek. Foundry: SMIC, Hua Hong,
TSMC, UMC, Vanguard and Win Semi. OSAT: JCET, Huatian, Tongfu, ASE, Chipbond, and KYEC.

Source: Company data, Data compiled by Goldman Sachs Global Investment Research
For the exclusive use of ALLEN.HAI@KGI.COM

Exhibit 3: IC design/IDM inventory value declined by 1% QoQ in Exhibit 4: IC distributors’ inventory value down declined by 1% QoQ
1Q23; inventory days remained flat QoQ (190 days) in 1Q23; inventory days was up to 69 days (vs 63 days in 4Q22)

(US$mn) (US$mn) Inventory Inventory days


Inventory Inventory days
190 200 10,000 80
16,000
9,000 69
180 70
14,000
8,000
160 60
12,000 7,000 52
140
45 50
10,000 111 129 120 6,000
37
8,000 100 5,000 40

80 4,000 30
6,000 89
60 3,000
4,000 20
40 2,000
2,000 1,000 10
20
- - - -
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19

4Q22
1Q23
1Q15

2Q16

3Q17

4Q18

1Q20

2Q21

3Q22

1Q15
2Q15
3Q15
4Q15
1Q16
2Q16
3Q16
4Q16
1Q17

3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
2Q22
3Q22
2Q15
3Q15
4Q15
1Q16

3Q16
4Q16
1Q17
2Q17

4Q17
1Q18
2Q18
3Q18

1Q19
2Q19
3Q19
4Q19

2Q20
3Q20
4Q20
1Q21

3Q21
4Q21
1Q22
2Q22

4Q22
1Q23

b2517faa3a7e11e094d300215ad26546
Source: Company data, Data compiled by Goldman Sachs Global Investment Research Source: Company data

Exhibit 5: TSMC’s revenue growth (in USD term) Exhibit 6: TSMC’s margin trend

120,000 40% 65%


35%
100,000 30% 60%

25%
80,000 55%
20%
15% 50%
60,000
10%
5% 45%
40,000
0%
40%
20,000 -5%
-10%
35%
0 -15%
2023E

2024E

2025E
2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

30%
2011 2013 2015 2017 2019 2021 2023E 2025E

Total revenue (USDmn) YoY (%, RHS) GM OpM NM

Source: Company data, Goldman Sachs Global Investment Research Source: Company data, Goldman Sachs Global Investment Research

22 May 2023 3
Goldman Sachs TSMC (2330.TW)

Exhibit 7: TSMC capex revisions (GSe) Exhibit 8: TSMC’s capex outlook

45 (US$bn)
40.0
36.3 36.0
40.0 35.0
40 30.9
30.0
36.0 30.0 27.0
35 25.0
32.0 32.0
30.9 20.0 17.2
30 15.0
27.0 15.0
9.7 9.5 10.2 10.9 10.5
10.0 8.3 8.1
25
5.0

20 -
2023E 2024E 2025E

2024E

2025E
2023E
2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022
Old forecast New forecast

Source: Goldman Sachs Global Investment Research Source: Company data, Goldman Sachs Global Investment Research

Forecast changes
We revise down our 2023-2025E EPS estimates by 5.0%/2.9%/3.4% mainly to factor in
a lower UTR assumptions for 5nm, 7nm and mature nodes on back of the slower end
demand. Net net, we are now expecting -10.0%/+27.7% revenue (in USD term) YoY in
For the exclusive use of ALLEN.HAI@KGI.COM

2023/2024E, with GpM to be 52.7%/53.6% and EPS at NT$28.35/NT$38.43.

Exhibit 9: Forecast changes


2023E 2024E 2025E
(NT$mn) Old New Diff (%) Old New Diff (%) Old New Diff (%)
Revenue 2,140,808 2,076,812 -3.0% 2,742,903 2,653,030 -3.3% 3,187,586 3,089,606 -3.1%
Gross profit 1,142,463 1,094,048 -4.2% 1,488,491 1,422,976 -4.4% 1,744,472 1,664,420 -4.6%
Op. income 890,315 845,758 -5.0% 1,190,843 1,150,138 -3.4% 1,398,624 1,346,383 -3.7%
Net income 773,518 735,110 -5.0% 1,026,475 996,571 -2.9% 1,207,975 1,166,988 -3.4%
EPS (NT$) 29.83 28.35 -5.0% 39.59 38.43 -2.9% 46.59 45.00 -3.4%
GM 53.4% 52.7% -0.7% 54.3% 53.6% -0.6% 54.7% 53.9% -0.9%
OpM 41.6% 40.7% -0.9% 43.4% 43.4% -0.1% 43.9% 43.6% -0.3%
NM 36.1% 35.4% -0.7% 37.4% 37.6% 0.1% 37.9% 37.8% -0.1%

2Q23E 3Q23E 4Q23E


(NT$mn) Old New Diff (%) Old New Diff (%) Old New Diff (%)

b2517faa3a7e11e094d300215ad26546
Revenue 480,499 475,277 -1.1% 524,961 519,615 -1.0% 626,715 573,288 -8.5%
Gross profit 254,518 251,785 -1.1% 271,427 269,243 -0.8% 330,018 286,520 -13.2%
Op. income 194,456 191,676 -1.4% 205,765 203,533 -1.1% 258,856 219,311 -15.3%
Net income 166,965 164,466 -1.5% 176,987 174,929 -1.2% 222,580 188,728 -15.2%
EPS (NT$) 6.44 6.34 -1.5% 6.83 6.75 -1.2% 8.58 7.28 -15.2%
GM 53.0% 53.0% 0.0% 51.7% 51.8% 0.1% 52.7% 50.0% -2.7%
OpM 40.5% 40.3% -0.1% 39.2% 39.2% 0.0% 41.3% 38.3% -3.0%
NM 34.7% 34.6% -0.1% 33.7% 33.7% 0.0% 35.5% 32.9% -2.6%

Source: Goldman Sachs Global Investment Research

Reiterate Buy; update TP to NT$615 from NT$633


Following our earnings revisions, our 12m TP is lowered to NT$615 from NT$633, still
based on a target PE multiple of 16x (in line with TSMC’s 3-year trading average during
the pre-Covid period in 2017-2019) to our 2024E EPS. Our 12 month TP for the ADR is
also updated to US$101 accordingly, from US$104, based on FX conversion (USD/TWD
of 30.4, unchanged).

Our NT$615 TP implies c.16% upside to the company’s last closing price. We maintain
our constructive view towards TSMC’s long-term growth outlook. In particular, we like
the stock as we believe the company’s solid technology leadership and execution make

22 May 2023 4
Goldman Sachs TSMC (2330.TW)

it better-positioned vs. peers to capture the industry’s long-term structural growth,


particularly in areas such as 5G/AI/HPC/EV. We reiterate our Buy rating on TSMC (also
Buy on ADR), as we believe its new strategy focused on overseas expansion will help to
improve the sentiment around geopolitical concerns and to support its share price
performance.

Key downside risks to our views: (1) further deterioration in end-demand recovery
impacting capacity utilization; (2) slower customer node migrations; (3) further delays in
5G penetration resulting in slower long-term semiconductor content growth; (4) poor
yields/execution resulting in worse-than-expected profitability; (5) stronger competition
resulting in ASP/profitability erosion; and (6) higher-than-expected cost increase
weighing on margin outlook.

Exhibit 10: Taiex vs. TSMC Exhibit 11: Forward P/E

21,000 800 1,200

18,000 700 1,000

15,000 600 26x


800
22x
For the exclusive use of ALLEN.HAI@KGI.COM

12,000 500
600 18x
9,000 400 14x
400
6,000 300 10x

200
3,000 200

0 100 0
Jan-15 Jan-16 Jan-17 Jan-18 Jan-19 Jan-20 Jan-21 Jan-22 Jan-23 Jan-11 Jan-13 Jan-15 Jan-17 Jan-19 Jan-21 Jan-23

Taiex TSMC (RHS, NT$) Price (NT$)

Source: Bloomberg Source: Bloomberg

Exhibit 12: Forward P/B Exhibit 13: P/B vs. ROE

1,800 40% 10.0

1,600 35% 9.0

b2517faa3a7e11e094d300215ad26546
10x 8.0
1,400 30%
7.0
1,200 8x
25% 6.0
1,000
20% 5.0
800 6x
15% 4.0
600 4x 3.0
10%
400 2.0
2x
5% 1.0
200

0 0% 0.0
Jan-11 Jan-13 Jan-15 Jan-17 Jan-19 Jan-21 Jan-23 Jan-11 Jan-13 Jan-15 Jan-17 Jan-19 Jan-21 Jan-23

ROE (LHS) Fwd P/B (RHS)


Price (NT$)

Source: Bloomberg Source: Bloomberg

22 May 2023 5
Goldman Sachs TSMC (2330.TW)

Investment Thesis, Price Target Risks and Methodology

Investment Thesis - TSMC (2330.TW/TSM)


TSMC is a leading global foundry company specializing in cutting-edge nodes. Its leading
technology stance enables it to enjoy a 60% share in the global foundry market. We like
TSMC as we think its solid technology leadership and execution better position it vs.
peers to capture the industry’s long-term structural growth, particularly in areas such as
5G/AI/HPC/EV. In addition, valuation looks attractive, with the shares trading at the lower
end of their 10-year trading history (P/E: 10-27x). Despite a choppy near-term outlook,
we believe TSMC will achieve its 15-20% revenue CAGR target for the next several
years, driven primarily by mid-to-high single digit % silicon content growth and HPC
demand, with GM to remain at 53%+. We favor TSMC’s leadership position with
long-term growth opportunity underpinned by the structural industry trend. We are Buy
rated on the stock.
For the exclusive use of ALLEN.HAI@KGI.COM

Price Target Risks and Methodology - TSMC (2330.TW/TSM)


Valuation: We are Buy rated on TSMC, with a 12m TP of NT$615, which is derived by
applying a target P/E multiple of 16x (inline with its 3-year trading average during the
pre-Covid period in 2017-2019) to 2024E EPS. We are Buy rated on the ADR (TSM) with
a 12m TP of US$101, based on a FX conversion (USD/TWD of 30.4).

Key downside risks to our views: (1) further deterioration in end-demand recovery
impacting capacity utilization; (2) slower customer node migrations; (3) further delays in
5G penetration resulting in slower long-term semiconductor content growth; (4) poor
yields/execution resulting in worse-than-expected profitability; (5) stronger competition
resulting in ASP/profitability erosion; and (6) higher-than-expected cost increase

b2517faa3a7e11e094d300215ad26546
weighing on margin outlook.

22 May 2023 6
Goldman Sachs TSMC (2330.TW)

Disclosure Appendix
Reg AC
We, Bruce Lu and Evelyn Yu, hereby certify that all of the views expressed in this report accurately reflect our personal views about the subject
company or companies and its or their securities. We also certify that no part of our compensation was, is or will be, directly or indirectly, related to the
specific recommendations or views expressed in this report.
Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Goldman Sachs’ Global Investment Research division.

GS Factor Profile
The Goldman Sachs Factor Profile provides investment context for a stock by comparing key attributes to the market (i.e. our coverage universe) and its
sector peers. The four key attributes depicted are: Growth, Financial Returns, Multiple (e.g. valuation) and Integrated (a composite of Growth, Financial
Returns and Multiple). Growth, Financial Returns and Multiple are calculated by using normalized ranks for specific metrics for each stock. The
normalized ranks for the metrics are then averaged and converted into percentiles for the relevant attribute. The precise calculation of each metric may
vary depending on the fiscal year, industry and region, but the standard approach is as follows:
Growth is based on a stock’s forward-looking sales growth, EBITDA growth and EPS growth (for financial stocks, only EPS and sales growth), with a
higher percentile indicating a higher growth company. Financial Returns is based on a stock’s forward-looking ROE, ROCE and CROCI (for financial
stocks, only ROE), with a higher percentile indicating a company with higher financial returns. Multiple is based on a stock’s forward-looking P/E, P/B,
price/dividend (P/D), EV/EBITDA, EV/FCF and EV/Debt Adjusted Cash Flow (DACF) (for financial stocks, only P/E, P/B and P/D), with a higher percentile
indicating a stock trading at a higher multiple. The Integrated percentile is calculated as the average of the Growth percentile, Financial Returns
percentile and (100% - Multiple percentile).
Financial Returns and Multiple use the Goldman Sachs analyst forecasts at the fiscal year-end at least three quarters in the future. Growth uses inputs
for the fiscal year at least seven quarters in the future compared with the year at least three quarters in the future (on a per-share basis for all metrics).
For a more detailed description of how we calculate the GS Factor Profile, please contact your GS representative.
For the exclusive use of ALLEN.HAI@KGI.COM

M&A Rank
Across our global coverage, we examine stocks using an M&A framework, considering both qualitative factors and quantitative factors (which may vary
across sectors and regions) to incorporate the potential that certain companies could be acquired. We then assign a M&A rank as a means of scoring
companies under our rated coverage from 1 to 3, with 1 representing high (30%-50%) probability of the company becoming an acquisition target, 2
representing medium (15%-30%) probability and 3 representing low (0%-15%) probability. For companies ranked 1 or 2, in line with our standard
departmental guidelines we incorporate an M&A component into our target price. M&A rank of 3 is considered immaterial and therefore does not
factor into our price target, and may or may not be discussed in research.

Quantum
Quantum is Goldman Sachs’ proprietary database providing access to detailed financial statement histories, forecasts and ratios. It can be used for
in-depth analysis of a single company, or to make comparisons between companies in different sectors and markets.

Disclosures
The rating(s) for TSMC and TSMC (ADR) is/are relative to the other companies in its/their coverage universe: ASE Technology Holding, ASE
Technology Holding (ADR), Chipbond Technology Corp., GlobalWafers Co., King Yuan Electronics Co., MediaTek, Novatek Microelectronics, Parade
Technologies Ltd., Realtek Semiconductor Corp., Silergy Corp., TSMC, TSMC (ADR), United Microelectronics Corp., United Microelectronics Corp.
(ADR), Vanguard International Corp., uPI

b2517faa3a7e11e094d300215ad26546
Company-specific regulatory disclosures
The following disclosures relate to relationships between The Goldman Sachs Group, Inc. (with its affiliates, “Goldman Sachs”) and companies covered
by Goldman Sachs Global Investment Research and referred to in this research.
Goldman Sachs has received compensation for investment banking services in the past 12 months: TSMC (NT$531.00) and TSMC (ADR) ($92.58)
Goldman Sachs expects to receive or intends to seek compensation for investment banking services in the next 3 months: TSMC (NT$531.00) and
TSMC (ADR) ($92.58)
Goldman Sachs has received compensation for non-investment banking services during the past 12 months: TSMC (NT$531.00) and TSMC (ADR)
($92.58)
Goldman Sachs had an investment banking services client relationship during the past 12 months with: TSMC (NT$531.00) and TSMC (ADR) ($92.58)
Goldman Sachs had a non-investment banking securities-related services client relationship during the past 12 months with: TSMC (NT$531.00) and
TSMC (ADR) ($92.58)
Goldman Sachs had a non-securities services client relationship during the past 12 months with: TSMC (NT$531.00) and TSMC (ADR) ($92.58)
Goldman Sachs makes a market in the securities or derivatives thereof: TSMC (NT$531.00) and TSMC (ADR) ($92.58)
Goldman Sachs is a specialist in the relevant securities and will at any given time have an inventory position, “long” or “short,” and may be on the
opposite side of orders executed on the relevant exchange: TSMC (NT$531.00) and TSMC (ADR) ($92.58)

Distribution of ratings/investment banking relationships


Goldman Sachs Investment Research global Equity coverage universe

Rating Distribution Investment Banking Relationships


Buy Hold Sell Buy Hold Sell
Global 48% 36% 16% 63% 56% 47%

22 May 2023 7
Goldman Sachs TSMC (2330.TW)

As of April 1, 2023, Goldman Sachs Global Investment Research had investment ratings on 3,026 equity securities. Goldman Sachs assigns stocks as
Buys and Sells on various regional Investment Lists; stocks not so assigned are deemed Neutral. Such assignments equate to Buy, Hold and Sell for
the purposes of the above disclosure required by the FINRA Rules. See ‘Ratings, Coverage universe and related definitions’ below. The Investment
Banking Relationships chart reflects the percentage of subject companies within each rating category for whom Goldman Sachs has provided
investment banking services within the previous twelve months.

Price target and rating history chart(s)


For the exclusive use of ALLEN.HAI@KGI.COM

Regulatory disclosures
Disclosures required by United States laws and regulations
See company-specific regulatory disclosures above for any of the following disclosures required as to companies referred to in this report: manager or
co-manager in a pending transaction; 1% or other ownership; compensation for certain services; types of client relationships; managed/co-managed
public offerings in prior periods; directorships; for equity securities, market making and/or specialist role. Goldman Sachs trades or may trade as a
principal in debt securities (or in related derivatives) of issuers discussed in this report.
The following are additional required disclosures: Ownership and material conflicts of interest: Goldman Sachs policy prohibits its analysts,
professionals reporting to analysts and members of their households from owning securities of any company in the analyst’s area of coverage.
Analyst compensation: Analysts are paid in part based on the profitability of Goldman Sachs, which includes investment banking revenues. Analyst
as officer or director: Goldman Sachs policy generally prohibits its analysts, persons reporting to analysts or members of their households from
serving as an officer, director or advisor of any company in the analyst’s area of coverage. Non-U.S. Analysts: Non-U.S. analysts may not be
associated persons of Goldman Sachs & Co. LLC and therefore may not be subject to FINRA Rule 2241 or FINRA Rule 2242 restrictions on
communications with subject company, public appearances and trading securities held by the analysts.
Distribution of ratings: See the distribution of ratings disclosure above. Price chart: See the price chart, with changes of ratings and price targets in
prior periods, above, or, if electronic format or if with respect to multiple companies which are the subject of this report, on the Goldman Sachs
website at https://www.gs.com/research/hedge.html.

b2517faa3a7e11e094d300215ad26546
Additional disclosures required under the laws and regulations of jurisdictions other than the United States
The following disclosures are those required by the jurisdiction indicated, except to the extent already made above pursuant to United States laws and
regulations. Australia: Goldman Sachs Australia Pty Ltd and its affiliates are not authorised deposit-taking institutions (as that term is defined in the
Banking Act 1959 (Cth)) in Australia and do not provide banking services, nor carry on a banking business, in Australia. This research, and any access to
it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act, unless otherwise agreed by Goldman Sachs. In
producing research reports, members of Global Investment Research of Goldman Sachs Australia may attend site visits and other meetings hosted by
the companies and other entities which are the subject of its research reports. In some instances the costs of such site visits or meetings may be met
in part or in whole by the issuers concerned if Goldman Sachs Australia considers it is appropriate and reasonable in the specific circumstances relating
to the site visit or meeting. To the extent that the contents of this document contains any financial product advice, it is general advice only and has
been prepared by Goldman Sachs without taking into account a client’s objectives, financial situation or needs. A client should, before acting on any
such advice, consider the appropriateness of the advice having regard to the client’s own objectives, financial situation and needs. A copy of certain
Goldman Sachs Australia and New Zealand disclosure of interests and a copy of Goldman Sachs’ Australian Sell-Side Research Independence Policy
Statement are available at: https://www.goldmansachs.com/disclosures/australia-new-zealand/index.html. Brazil: Disclosure information in relation to
CVM Resolution n. 20 is available at https://www.gs.com/worldwide/brazil/area/gir/index.html. Where applicable, the Brazil-registered analyst primarily
responsible for the content of this research report, as defined in Article 20 of CVM Resolution n. 20, is the first author named at the beginning of this
report, unless indicated otherwise at the end of the text. Canada: This information is being provided to you for information purposes only and is not,
and under no circumstances should be construed as, an advertisement, offering or solicitation by Goldman Sachs & Co. LLC for purchasers of
securities in Canada to trade in any Canadian security. Goldman Sachs & Co. LLC is not registered as a dealer in any jurisdiction in Canada under
applicable Canadian securities laws and generally is not permitted to trade in Canadian securities and may be prohibited from selling certain securities
and products in certain jurisdictions in Canada. If you wish to trade in any Canadian securities or other products in Canada please contact Goldman
Sachs Canada Inc., an affiliate of The Goldman Sachs Group Inc., or another registered Canadian dealer. Hong Kong: Further information on the
securities of covered companies referred to in this research may be obtained on request from Goldman Sachs (Asia) L.L.C. India: Further information
on the subject company or companies referred to in this research may be obtained from Goldman Sachs (India) Securities Private Limited, Research
Analyst - SEBI Registration Number INH000001493, 951-A, Rational House, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025, India, Corporate
Identity Number U74140MH2006FTC160634, Phone +91 22 6616 9000, Fax +91 22 6616 9001. Goldman Sachs may beneficially own 1% or more of
the securities (as such term is defined in clause 2 (h) the Indian Securities Contracts (Regulation) Act, 1956) of the subject company or companies
referred to in this research report. Japan: See below. Korea: This research, and any access to it, is intended only for “professional investors” within
the meaning of the Financial Services and Capital Markets Act, unless otherwise agreed by Goldman Sachs. Further information on the subject
company or companies referred to in this research may be obtained from Goldman Sachs (Asia) L.L.C., Seoul Branch. New Zealand: Goldman Sachs
New Zealand Limited and its affiliates are neither “registered banks” nor “deposit takers” (as defined in the Reserve Bank of New Zealand Act 1989) in

22 May 2023 8
Goldman Sachs TSMC (2330.TW)

New Zealand. This research, and any access to it, is intended for “wholesale clients” (as defined in the Financial Advisers Act 2008) unless otherwise
agreed by Goldman Sachs. A copy of certain Goldman Sachs Australia and New Zealand disclosure of interests is available at:
https://www.goldmansachs.com/disclosures/australia-new-zealand/index.html. Russia: Research reports distributed in the Russian Federation are not
advertising as defined in the Russian legislation, but are information and analysis not having product promotion as their main purpose and do not
provide appraisal within the meaning of the Russian legislation on appraisal activity. Research reports do not constitute a personalized investment
recommendation as defined in Russian laws and regulations, are not addressed to a specific client, and are prepared without analyzing the financial
circumstances, investment profiles or risk profiles of clients. Goldman Sachs assumes no responsibility for any investment decisions that may be taken
by a client or any other person based on this research report. Singapore: Goldman Sachs (Singapore) Pte. (Company Number: 198602165W), which is
regulated by the Monetary Authority of Singapore, accepts legal responsibility for this research, and should be contacted with respect to any matters
arising from, or in connection with, this research. Taiwan: This material is for reference only and must not be reprinted without permission. Investors
should carefully consider their own investment risk. Investment results are the responsibility of the individual investor. United Kingdom: Persons who
would be categorized as retail clients in the United Kingdom, as such term is defined in the rules of the Financial Conduct Authority, should read this
research in conjunction with prior Goldman Sachs research on the covered companies referred to herein and should refer to the risk warnings that have
been sent to them by Goldman Sachs International. A copy of these risks warnings, and a glossary of certain financial terms used in this report, are
available from Goldman Sachs International on request.
European Union and United Kingdom: Disclosure information in relation to Article 6 (2) of the European Commission Delegated Regulation (EU)
(2016/958) supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council (including as that Delegated Regulation is
implemented into United Kingdom domestic law and regulation following the United Kingdom’s departure from the European Union and the European
Economic Area) with regard to regulatory technical standards for the technical arrangements for objective presentation of investment
recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of
conflicts of interest is available at https://www.gs.com/disclosures/europeanpolicy.html which states the European Policy for Managing Conflicts of
Interest in Connection with Investment Research.
Japan: Goldman Sachs Japan Co., Ltd. is a Financial Instrument Dealer registered with the Kanto Financial Bureau under registration number Kinsho
69, and a member of Japan Securities Dealers Association, Financial Futures Association of Japan Type II Financial Instruments Firms Association, The
Investment Trusts Association, Japan, and Japan Investment Advisers Association. Sales and purchase of equities are subject to commission
pre-determined with clients plus consumption tax. See company-specific disclosures as to any applicable disclosures required by Japanese stock
exchanges, the Japanese Securities Dealers Association or the Japanese Securities Finance Company.

Ratings, coverage universe and related definitions


For the exclusive use of ALLEN.HAI@KGI.COM

Buy (B), Neutral (N), Sell (S) Analysts recommend stocks as Buys or Sells for inclusion on various regional Investment Lists. Being assigned a Buy or
Sell on an Investment List is determined by a stock’s total return potential relative to its coverage universe. Any stock not assigned as a Buy or a Sell on
an Investment List with an active rating (i.e., a stock that is not Rating Suspended, Not Rated, Coverage Suspended or Not Covered), is deemed
Neutral. Each region manages Regional Conviction lists, which are selected from Buy rated stocks on the respective region’s Investment lists and
represent investment recommendations focused on the size of the total return potential and/or the likelihood of the realization of the return across their
respective areas of coverage. The addition or removal of stocks from such Conviction lists are managed by the Investment Review Committee or other
designated committee in each respective region and do not represent a change in the analysts’ investment rating for such stocks.
Total return potential represents the upside or downside differential between the current share price and the price target, including all paid or
anticipated dividends, expected during the time horizon associated with the price target. Price targets are required for all covered stocks. The total
return potential, price target and associated time horizon are stated in each report adding or reiterating an Investment List membership.
Coverage Universe: A list of all stocks in each coverage universe is available by primary analyst, stock and coverage universe at
https://www.gs.com/research/hedge.html.
Not Rated (NR). The investment rating, target price and earnings estimates (where relevant) have been suspended pursuant to Goldman Sachs policy
when Goldman Sachs is acting in an advisory capacity in a merger or in a strategic transaction involving this company, when there are legal, regulatory
or policy constraints due to Goldman Sachs’ involvement in a transaction, and in certain other circumstances. Rating Suspended (RS). Goldman
Sachs Research has suspended the investment rating and price target for this stock, because there is not a sufficient fundamental basis for
determining an investment rating or target price. The previous investment rating and target price, if any, are no longer in effect for this stock and should

b2517faa3a7e11e094d300215ad26546
not be relied upon. Coverage Suspended (CS). Goldman Sachs has suspended coverage of this company. Not Covered (NC). Goldman Sachs does
not cover this company. Not Available or Not Applicable (NA). The information is not available for display or is not applicable. Not Meaningful
(NM). The information is not meaningful and is therefore excluded.

Global product; distributing entities


Goldman Sachs Global Investment Research produces and distributes research products for clients of Goldman Sachs on a global basis. Analysts based
in Goldman Sachs offices around the world produce research on industries and companies, and research on macroeconomics, currencies, commodities
and portfolio strategy. This research is disseminated in Australia by Goldman Sachs Australia Pty Ltd (ABN 21 006 797 897); in Brazil by Goldman Sachs
do Brasil Corretora de Títulos e Valores Mobiliários S.A.; Public Communication Channel Goldman Sachs Brazil: 0800 727 5764 and / or
contatogoldmanbrasil@gs.com. Available Weekdays (except holidays), from 9am to 6pm. Canal de Comunicação com o Público Goldman Sachs Brasil:
0800 727 5764 e/ou contatogoldmanbrasil@gs.com. Horário de funcionamento: segunda-feira à sexta-feira (exceto feriados), das 9h às 18h; in Canada
by Goldman Sachs & Co. LLC; in Hong Kong by Goldman Sachs (Asia) L.L.C.; in India by Goldman Sachs (India) Securities Private Ltd.; in Japan by
Goldman Sachs Japan Co., Ltd.; in the Republic of Korea by Goldman Sachs (Asia) L.L.C., Seoul Branch; in New Zealand by Goldman Sachs New
Zealand Limited; in Russia by OOO Goldman Sachs; in Singapore by Goldman Sachs (Singapore) Pte. (Company Number: 198602165W); and in the
United States of America by Goldman Sachs & Co. LLC. Goldman Sachs International has approved this research in connection with its distribution in
the United Kingdom.
Goldman Sachs International (“GSI”), authorised by the Prudential Regulation Authority (“PRA”) and regulated by the Financial Conduct Authority
(“FCA”) and the PRA, has approved this research in connection with its distribution in the United Kingdom.
European Economic Area: GSI, authorised by the PRA and regulated by the FCA and the PRA, disseminates research in the following jurisdictions
within the European Economic Area: the Grand Duchy of Luxembourg, Italy, the Kingdom of Belgium, the Kingdom of Denmark, the Kingdom of
Norway, the Republic of Finland and the Republic of Ireland; GSI - Succursale de Paris (Paris branch) which is authorised by the French Autorité de
contrôle prudentiel et de resolution (“ACPR”) and regulated by the Autorité de contrôle prudentiel et de resolution and the Autorité des marches
financiers (“AMF”) disseminates research in France; GSI - Sucursal en España (Madrid branch) authorized in Spain by the Comisión Nacional del
Mercado de Valores disseminates research in the Kingdom of Spain; GSI - Sweden Bankfilial (Stockholm branch) is authorized by the SFSA as a “third
country branch” in accordance with Chapter 4, Section 4 of the Swedish Securities and Market Act (Sw. lag (2007:528) om värdepappersmarknaden)
disseminates research in the Kingdom of Sweden; Goldman Sachs Bank Europe SE (“GSBE”) is a credit institution incorporated in Germany and, within
the Single Supervisory Mechanism, subject to direct prudential supervision by the European Central Bank and in other respects supervised by German
Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and Deutsche Bundesbank and disseminates research

22 May 2023 9
Goldman Sachs TSMC (2330.TW)

in the Federal Republic of Germany and those jurisdictions within the European Economic Area where GSI is not authorised to disseminate research
and additionally, GSBE, Copenhagen Branch filial af GSBE, Tyskland, supervised by the Danish Financial Authority disseminates research in the Kingdom
of Denmark; GSBE - Sucursal en España (Madrid branch) subject (to a limited extent) to local supervision by the Bank of Spain disseminates research in
the Kingdom of Spain; GSBE - Succursale Italia (Milan branch) to the relevant applicable extent, subject to local supervision by the Bank of Italy (Banca
d’Italia) and the Italian Companies and Exchange Commission (Commissione Nazionale per le Società e la Borsa “Consob”) disseminates research in
Italy; GSBE - Succursale de Paris (Paris branch), supervised by the AMF and by the ACPR disseminates research in France; and GSBE - Sweden
Bankfilial (Stockholm branch), to a limited extent, subject to local supervision by the Swedish Financial Supervisory Authority (Finansinpektionen)
disseminates research in the Kingdom of Sweden.

General disclosures
This research is for our clients only. Other than disclosures relating to Goldman Sachs, this research is based on current public information that we
consider reliable, but we do not represent it is accurate or complete, and it should not be relied on as such. The information, opinions, estimates and
forecasts contained herein are as of the date hereof and are subject to change without prior notification. We seek to update our research as
appropriate, but various regulations may prevent us from doing so. Other than certain industry reports published on a periodic basis, the large majority
of reports are published at irregular intervals as appropriate in the analyst’s judgment.
Goldman Sachs conducts a global full-service, integrated investment banking, investment management, and brokerage business. We have investment
banking and other business relationships with a substantial percentage of the companies covered by Global Investment Research. Goldman Sachs &
Co. LLC, the United States broker dealer, is a member of SIPC (https://www.sipc.org).
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients and principal
trading desks that reflect opinions that are contrary to the opinions expressed in this research. Our asset management area, principal trading desks and
investing businesses may make investment decisions that are inconsistent with the recommendations or views expressed in this research.
The analysts named in this report may have from time to time discussed with our clients, including Goldman Sachs salespersons and traders, or may
discuss in this report, trading strategies that reference catalysts or events that may have a near-term impact on the market price of the equity securities
discussed in this report, which impact may be directionally counter to the analyst’s published price target expectations for such stocks. Any such
trading strategies are distinct from and do not affect the analyst’s fundamental equity rating for such stocks, which rating reflects a stock’s return
potential relative to its coverage universe as described herein.
We and our affiliates, officers, directors, and employees will from time to time have long or short positions in, act as principal in, and buy or sell, the
For the exclusive use of ALLEN.HAI@KGI.COM

securities or derivatives, if any, referred to in this research, unless otherwise prohibited by regulation or Goldman Sachs policy.
The views attributed to third party presenters at Goldman Sachs arranged conferences, including individuals from other parts of Goldman Sachs, do not
necessarily reflect those of Global Investment Research and are not an official view of Goldman Sachs.
Any third party referenced herein, including any salespeople, traders and other professionals or members of their household, may have positions in the
products mentioned that are inconsistent with the views expressed by analysts named in this report.
This research is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be
illegal. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of
individual clients. Clients should consider whether any advice or recommendation in this research is suitable for their particular circumstances and, if
appropriate, seek professional advice, including tax advice. The price and value of investments referred to in this research and the income from them
may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur.
Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.
Certain transactions, including those involving futures, options, and other derivatives, give rise to substantial risk and are not suitable for all investors.
Investors should review current options and futures disclosure documents which are available from Goldman Sachs sales representatives or at
https://www.theocc.com/about/publications/character-risks.jsp and
https://www.fiadocumentation.org/fia/regulatory-disclosures_1/fia-uniform-futures-and-options-on-futures-risk-disclosures-booklet-pdf-version-2018.
Transaction costs may be significant in option strategies calling for multiple purchase and sales of options such as spreads. Supporting documentation
will be supplied upon request.

b2517faa3a7e11e094d300215ad26546
Differing Levels of Service provided by Global Investment Research: The level and types of services provided to you by Goldman Sachs Global
Investment Research may vary as compared to that provided to internal and other external clients of GS, depending on various factors including your
individual preferences as to the frequency and manner of receiving communication, your risk profile and investment focus and perspective (e.g.,
marketwide, sector specific, long term, short term), the size and scope of your overall client relationship with GS, and legal and regulatory constraints.
As an example, certain clients may request to receive notifications when research on specific securities is published, and certain clients may request
that specific data underlying analysts’ fundamental analysis available on our internal client websites be delivered to them electronically through data
feeds or otherwise. No change to an analyst’s fundamental research views (e.g., ratings, price targets, or material changes to earnings estimates for
equity securities), will be communicated to any client prior to inclusion of such information in a research report broadly disseminated through electronic
publication to our internal client websites or through other means, as necessary, to all clients who are entitled to receive such reports.
All research reports are disseminated and available to all clients simultaneously through electronic publication to our internal client websites. Not all
research content is redistributed to our clients or available to third-party aggregators, nor is Goldman Sachs responsible for the redistribution of our
research by third party aggregators. For research, models or other data related to one or more securities, markets or asset classes (including related
services) that may be available to you, please contact your GS representative or go to https://research.gs.com.
Disclosure information is also available at https://www.gs.com/research/hedge.html or from Research Compliance, 200 West Street, New York, NY
10282.
© 2023 Goldman Sachs.
No part of this material may be (i) copied, photocopied or duplicated in any form by any means or (ii) redistributed without the prior written
consent of The Goldman Sachs Group, Inc.

22 May 2023 10

You might also like